FilingSEC EDGAR8-K
Vistagen Therapeutics Amends Executive Severance Plan to Expand Benefits
· SEC accepted
StageCompleted
Filing content
The company amended its executive severance plan to provide benefits for involuntary terminations without cause, regardless of whether the termination occurs in connection with a change in control.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…